Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Top News

GS1 Philippines fights fake medicine

by
October 9, 2024
in Top News
0
GS1 Philippines fights fake medicine
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter
REUTERS

ADOPTION of barcode technology could help the Philippines fight counterfeit medicines and medical supplies, an advocacy group said on Wednesday following the country’s inclusion in a US watchlist for pharmaceutical crimes.

“By leveraging barcode technology, we can establish a cohesive integration of global standards that prioritizes patient safety, particularly in regions facing serious challenges with counterfeit products,” said Roberto “Bobby” S. Claudio, president of GS1 Philippines.

The United States Trade Representative named the Philippines as one of the leading sources of counterfeit medicines distributed worldwide.

It also cited the country in its US piracy watchlist for growing concerns about the manufacture and distribution of counterfeit pharmaceutical products.

In response, GS1 Philippines has been implementing Global Trade Item Numbers (GTINs). This standardizes labeling and tracking systems, streamlines the management of medicines and supplies, and improves the supply chain.

GS1 Philippines said GTINs improve product identification and verification as it can capture the date of manufacture, expiration date, and the name of manufacturer.

The group said it is also committed to preparing local industries for the global shift to 2D barcodes by 2027, aligning with international standards and enhancing the country’s competitiveness.

The 2D barcodes, including QR codes, ensure accurate brand information and better supply chain management. — Aubrey Rose A. Inosante

ShareTweetPin

Related Posts

Have a taste of the perfect day in paradise with SULÀ Spirits
Top News

Have a taste of the perfect day in paradise with SULÀ Spirits

January 8, 2025
First months of 2025 likely rainy amid La Niña conditions, says PAGASA
Top News

First months of 2025 likely rainy amid La Niña conditions, says PAGASA

January 8, 2025
December inflation rises to 2.9%
Top News

December inflation rises to 2.9%

January 7, 2025
Outstanding debt hits fresh high of P16.09T
Top News

Outstanding debt hits fresh high of P16.09T

January 7, 2025
Outstanding debt hits fresh high of P16.09T
Top News

Outstanding debt hits fresh high of P16.09T

January 7, 2025
PHL end-December dollar reserves drop to $106.8B
Top News

PHL end-December dollar reserves drop to $106.8B

January 7, 2025
Next Post
P111M worth of drugs seized

P111M worth of drugs seized

Recommended

Expanding a good thing to make it better: The Philippines’ GASTPE experience

Expanding a good thing to make it better: The Philippines’ GASTPE experience

November 26, 2024
Seat Unique Secures £14.5 Million Funding, Expands Advisory Board as Experience Economy Soars

Seat Unique Secures £14.5 Million Funding, Expands Advisory Board as Experience Economy Soars

August 29, 2024
Post Office faces backlash over potential closure of 115 branches as jobs and services are at risk

Post Office faces backlash over potential closure of 115 branches as jobs and services are at risk

November 13, 2024
Mapua Cardinals, Letran Knights clash for solo second place in NCAA S100

Mapua Cardinals, Letran Knights clash for solo second place in NCAA S100

September 19, 2024
Ipilan Nickel Corp.: Building a sustainable future together with indigenous communities

Ipilan Nickel Corp.: Building a sustainable future together with indigenous communities

November 26, 2024
Maynilad eyes April or July 2025 for IPO

Maynilad eyes April or July 2025 for IPO

November 10, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Terms & Conditions
    • Thank you

    Copyright © 2024 investdailypro.com | All Rights Reserved